Testosterone Replacement Therapy (TRT)

A typical TRT session depends on your delivery method. For injections, you'll receive an intramuscular shot (usually in the glute or thigh) administered by a healthcare provider or self-administered at home after training—taking 1–2 minutes. For topical gels or creams, you apply the medication to clean, dry skin daily at home. Patch users simply apply a new patch to clean skin. Pellet implantation, done in-office, involves a small surgical procedure under local anesthesia lasting 10–15 minutes. Blood draws for monitoring occur during office visits and take just minutes.

TRT is typically a long-term, ongoing treatment. If testosterone deficiency is confirmed, most men require continuous therapy to maintain hormone levels. The number of sessions varies by delivery method: injection patients visit monthly or every two weeks for administration and monitoring; topical users apply medication daily at home; pellet recipients return every 3–6 months for implantation. Blood work monitoring occurs at 6–8 weeks, 3 months, then annually. Most men continue TRT indefinitely unless contraindications develop or they choose to discontinue after discussing risks with their provider.

Symptom improvement timelines vary. Energy and mood often improve within 2–4 weeks. Sexual function (libido and erectile function) typically improves over 6–12 weeks. Muscle strength, mass, and body composition changes develop gradually over 3–6 months. Bone density improvements take even longer—usually 12+ months. Some men notice minimal change if their baseline symptoms were mild or if other factors (like depression or relationship issues) contribute. Dose optimization during the first few months may be needed to achieve your best response.

Common side effects include acne or oily skin, increased body hair growth, mood changes (sometimes increased aggression or irritability), and mild fluid retention. Some men experience breast tenderness or enlargement (gynecomastia). Injection sites may become sore or develop bruising. Sleep apnea symptoms may worsen. More serious but less common risks include elevated red blood cell count (polycythemia), increased blood pressure, liver enzyme elevation, and in some studies, increased cardiovascular risk in vulnerable men. Regular monitoring helps catch and manage side effects early.

TRT is generally not permanent in the sense that stopping treatment typically leads to testosterone levels returning to baseline over weeks to months. Some men with primary hypogonadism may never recover natural production even after stopping. Others, particularly those with age-related decline, may experience gradual return of some testosterone production. Discuss with your provider before stopping—abrupt discontinuation can cause symptoms to return. Many men continue TRT indefinitely once started because benefits stop when treatment ends and their natural testosterone remains low.

Monitoring is essential and involves regular blood tests measuring testosterone levels, hemoglobin/hematocrit (to check for polycythemia), liver function, and lipid profile. PSA and digital rectal exams are performed at baseline and annually to screen for prostate issues. Blood pressure and weight are tracked at each visit. You'll discuss symptoms and side effects at follow-ups. Dose adjustments are based on blood work results and symptom response. Most practitioners recommend blood tests at 6–8 weeks after starting, again at 3 months, then annually. This monitoring helps ensure you're receiving an appropriate dose and that no serious side effects are developing.

TRT is not typically prescribed for women due to different hormonal physiology and higher risk of virilization (development of masculine characteristics). However, some women with specific conditions—such as female hypogonadism or certain cases of female sexual dysfunction—may benefit from very low-dose testosterone under specialized medical supervision. This is rare and requires careful evaluation by an endocrinologist or reproductive specialist. Women should never use testosterone formulations designed for men.

Yes, TRT typically suppresses sperm production and reduces fertility. Testosterone replacement suppresses luteinizing hormone (LH) and follicle-stimulating hormone (FSH), hormones necessary for sperm production. Men who wish to father children should discuss this with their provider before starting TRT. Some men may recover fertility after stopping therapy, but this is not guaranteed. If fertility is a concern, alternative treatments (like hCG or clomiphene) that preserve or restore sperm production may be options to discuss.